Mammalian Sirtuins: Biological Insights and Disease Relevance

By M. Haigis, D. Sinclair. Annual Review of Pathology, 2010

2,040 citations recorded by the source corpus.

Aging is accompanied by a decline in the healthy function of multiple organ systems, leading to increased incidence and mortality from diseases such as type II diabetes mellitus, neurodegenerative diseases, cancer, and cardiovascular disease. Historically, researchers have focused on investigating individual pathways in isolated organs as a strategy to identify the root cause of a disease, with hopes of designing better drugs. Studies of aging in yeast led to the discovery of a family of conserved enzymes known as the sirtuins, which affect multiple pathways that increase the life span and the overall health of organisms. Since the discovery of the first known mammalian sirtuin, SIRT1, 10 years ago, there have been major advances in our understanding of the enzymology of sirtuins, their regulation, and their ability to broadly improve mammalian physiology and health span. This review summarizes and discusses the advances of the past decade and the challenges that will confront the field in the coming years.

Subfields: Epidemiology, Geriatrics and Gerontology, Physiology

View Paper: https://www.semanticscholar.org/paper/cbfad45b325afc31c2d00a0f7e0b7f9cf5b10f58

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

  1. Guido Kroemer
  2. Guillermo Mariño
  3. D. Rubinsztein
  4. W. Kraus
  5. Luis A. Rajman
  6. Bor Luen Tang
  7. K. Chwalek
  8. E. Verdin

In Geriatrics and Gerontology

  1. Johan Auwerx
  2. E. Verdin
  3. D. Sinclair
  4. C. Cantó
  5. Joseph A. Baur
  6. R. Houtkooper
  7. S. Imai
  8. Bor Luen Tang

In Physiology

  1. E. Verdin
  2. Johan Auwerx
  3. D. Sinclair
  4. Joseph A. Baur
  5. S. Imai
  6. Guido Kroemer
  7. C. Cantó
  8. Adam Freund

Citations in the corpus